(Q41041011)

26 September 2017

title

Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects (English)

1 reference

26 September 2017

0 references

Henderson WR Jr

1

1 reference

26 September 2017

Astley SJ

2

1 reference

26 September 2017

McCready MM

3

1 reference

26 September 2017

Kushmerick P

4

1 reference

26 September 2017

Casey S

5

1 reference

26 September 2017

Becker JW

6

1 reference

26 September 2017

Ramsey BW

7

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 March 1994

1 reference

The Journal of Pediatrics

26 September 2017

published in

1 reference

26 September 2017

volume

124

1 reference

26 September 2017

issue

3

1 reference

26 September 2017

page(s)

400-408

1 reference

Eicosanoids and platelet-activating factor in allergic respiratory diseases

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

IDENTIFICATION OF LEUKOTRIENES D AND B IN SPUTUM FROM CYSTIC FIBROSIS PATIENTS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Detection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassay and radioimmunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Sputum cysteinyl‐leukotriene levels correlate with the severity of pulmonary disease in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Leukotrienes in the sputum and urine of cystic fibrosis children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Clinical applications of fish oils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Biosynthesis and biological activity of leukotriene B5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Dietary Supplementation with Fish Oil in Ulcerative Colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Effect of dietary supplementation with eicosapentaenoic acid in the treatment of atopic dermatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

A new prognostic score and clinical evaluation system for cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Physical growth: National Center for Health Statistics percentiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

New norms of upper limb fat and muscle areas for assessment of nutritional status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Abnormal fatty-acid composition of plasma-lipids in cystic fibrosis. A primary or a secondary defect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Abnormal levels of prostaglandins and fatty acids in blood of children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Altered phospholipid composition and changed fatty acid pattern of the various phospholipid fractions of red cell membranes of cystic fibrosis children with pancreatic insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Fatty acid abnormalities in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Absorption of safflower oil and structured lipid preparations in patients with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Abnormal fatty acid turnover in the phospholipids of the red blood cell membranes of cystic fibrosis patients (in vitro study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Biological Markers of Dietary Intake, with Emphasis on Fatty Acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Blood and Liver Concentrations of Vitamins A and E in Children with Cystic Fibrosis of the Pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

The occurrence and effects of human vitamin E deficiency. A study in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Eicosapentaenoic acid ethyl ester as an antithrombotic agent: comparison to an extract of fish oil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Effects of a 4-week freshwater fish (trout) diet on platelet aggregation, platelet fatty acids, serum lipids, and coagulation factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Dose-response effects of fish-oil supplementation in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Effects of a new fluid fish oil concentrate, ESKIMO-3, on triglycerides, cholesterol, fibrinogen and blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Increased incidence of epistaxis in adolescents with familial hypercholesterolemia treated with fish oil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Comparison of the macronutrient intake of healthy controls and children with cystic fibrosis on low fat or nonrestricted fat diets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

Nutritional requirements in cystic fibrosis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970362-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(94)70362-0

1 reference

26 September 2017

1 reference